There are 3.4 million people in the U.S. living with epilepsy, and for about a third of them, medication isn’t enough to prevent potentially life-threatening seizures. But the rapidly expanding field of neurotechnology offers alternative possibilities for many of these patients.
For Kate Faulkner, who was diagnosed with epilepsy in her early 20s, the fear of having a catastrophic seizure is ever-present. “It’s a very crushing limitation,” she says.
